Kits Eyecare estimates 2025 revenue of $202.5-million

Executive Summary

• Kits Eyecare Ltd. released selected preliminary unaudited Q4 2025 and full‑year 2025 financial highlights, showing strong revenue growth and expanding margins.
• Total revenue rose 20% YoY to ~​$53.9 M in Q4 and 27% YoY to ~​$202.5 M for the full year, indicating robust top‑line performance.
• Adjusted EBITDA margin improved to roughly 4–5% in Q4 and 5–6% for the year, reflecting improving profitability alongside higher glasses revenue and unit sales.

Key Details

• Q4 2025 Revenue: Approximately $53.9 million, up 20% YoY.
• Adjusted EBITDA Margin (Q4): Approximately 4.0‑5.0% of revenue.
• Glasses Revenue (Q4): $8.7 million, up ~33% YoY.
• Glasses Units Sold (Q4): 119,000 units, up 43% YoY.
• Full‑Year 2025 Revenue: Approximately $202.5 million, up 27% YoY.
• Adjusted EBITDA Margin (FY): Approximately 5.0‑6.0% of revenue.
• New Customer Additions (FY): ~393,000, up 30% YoY.
• Future Reporting: Audited Q4 and full‑year results to be released in early March 2026; conference call details to be disclosed in February 2026.